BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23406446)

  • 1. A retrospective matched case-control study on medical costs of refractory migraine in Taiwan.
    Tang CH; Chen YC; Ng K; Wang SJ
    Headache; 2013 Mar; 53(3):526-39. PubMed ID: 23406446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medical costs of migraine and comorbid anxiety and depression.
    Pesa J; Lage MJ
    Headache; 2004 Jun; 44(6):562-70. PubMed ID: 15186300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome.
    Bonafede M; Jing Y; Gdovin Bergeson J; Liffmann D; Makenbaeva D; Graham J; Deitelzweig SB
    Hosp Pract (1995); 2011 Aug; 39(3):16-22. PubMed ID: 21881388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
    Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
    Silberstein SD; Feliu AL; Rupnow MF; Blount AC; Boccuzzi SJ
    Headache; 2007 Apr; 47(4):500-10. PubMed ID: 17445099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare resource use and costs associated with migraine in a managed healthcare setting.
    Clouse JC; Osterhaus JT
    Ann Pharmacother; 1994 May; 28(5):659-64. PubMed ID: 8069007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan.
    Chen YC; Tang CH; Ng K; Wang SJ
    J Headache Pain; 2012 Jun; 13(4):311-9. PubMed ID: 22527034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
    Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
    Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Appl Health Econ Health Policy; 2011 Nov; 9(6):377-87. PubMed ID: 21888449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct cost burden among insured US employees with migraine.
    Hawkins K; Wang S; Rupnow M
    Headache; 2008 Apr; 48(4):553-63. PubMed ID: 18070057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Appl Health Econ Health Policy; 2011 Sep; 9(5):293-303. PubMed ID: 21875160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Buse DC; Saiers J; Serrano D; Reed ML
    J Med Econ; 2013; 16(4):490-9. PubMed ID: 23356422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the utility of in-clinic "rescue" therapy for acute migraine.
    Morey V; Rothrock JF
    Headache; 2008 Jun; 48(6):939-43. PubMed ID: 18549372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs associated with outpatient, emergency room and inpatient care for migraine in the USA.
    Insinga RP; Ng-Mak DS; Hanson ME
    Cephalalgia; 2011 Nov; 31(15):1570-5. PubMed ID: 22013140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Depression on Health and Medical Care Utilization and Expenses in US Adults With Migraine: A Retrospective Cross Sectional Study.
    Wu J; Davis-Ajami ML; Kevin Lu Z
    Headache; 2016 Jul; 56(7):1147-60. PubMed ID: 27350407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actuarial analysis of private payer administrative claims data for women with endometriosis.
    Mirkin D; Murphy-Barron C; Iwasaki K
    J Manag Care Pharm; 2007 Apr; 13(3):262-72. PubMed ID: 17407392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.